As if you need another reason to admire — her description of bi-specific antibodies for cancer in this story was simply brilliant. Anyone interested in this field (vs. CAR-T) needs to read:
They’re the next new thing in cancer immunotherapy, but will bispecifics help more patients than CAR-T?
They’re the next new thing in cancer immunotherapy, but will bispecifics help more patients than... via
They’re the next new thing in cancer immunotherapy, but will bispecifics help more patients than... via
In #cancer #Immunotherapy , CAR-T's and checkpoint inhibitors get the spotlight. Yet 40% of $AMGN onc pipeline is BiTEs. I delved into bispecific antibodies